These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 15569557

  • 1. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
    Aurangzeb B, Hameed A.
    J Coll Physicians Surg Pak; 2003 Dec; 13(12):704-7. PubMed ID: 15569557
    [Abstract] [Full Text] [Related]

  • 2. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
    Martin M, Moore L, Quilici S, Decramer M, Simoens S.
    Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
    [Abstract] [Full Text] [Related]

  • 3. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
    Kogan R, Martínez MA, Rubilar L, Payá E, Quevedo I, Puppo H, Girardi G, Castro-Rodriguez JA.
    Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
    [Abstract] [Full Text] [Related]

  • 4. Cefuroxime compared to amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.
    Oh HM, Ng AW, Lee SK.
    Singapore Med J; 1996 Jun; 37(3):255-7. PubMed ID: 8942221
    [Abstract] [Full Text] [Related]

  • 5. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
    Stein GE, Mantz SL.
    Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
    [Abstract] [Full Text] [Related]

  • 6. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
    Bradley JS, Arguedas A, Blumer JL, Sáez-Llorens X, Melkote R, Noel GJ.
    Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia.
    Bhavnani SM, Ambrose PG.
    Diagn Microbiol Infect Dis; 2008 Jan; 60(1):59-64. PubMed ID: 17889491
    [Abstract] [Full Text] [Related]

  • 8. An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia.
    Lin TY, Lin SM, Chen HC, Wang CJ, Wang YM, Chang ML, Wang CH, Liu CY, Lin HC, Yu CT, Hsieh LL, Kuo HP, Huang CD.
    Chang Gung Med J; 2007 Jan; 30(4):321-32. PubMed ID: 17939262
    [Abstract] [Full Text] [Related]

  • 9. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI, Wu MH, Huang LM, Chen JM, Lee CY.
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [Abstract] [Full Text] [Related]

  • 10. Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection.
    Quenzer RW, Pettit KG, Arnold RJ, Kaniecki DJ.
    Am J Manag Care; 1997 Jul; 3(7):1027-36. PubMed ID: 10173367
    [Abstract] [Full Text] [Related]

  • 11. Comparison of spiramycin and clarithromycin for community-acquired lower respiratory tract infections.
    Rocha RT, Awad CE, Ali A, Matyas R, Vital AC, Silva CO, Dainesi SM, Salazar MS, Nakatani J.
    Int J Clin Pract; 1999 Sep; 53(6):433-6. PubMed ID: 10622070
    [Abstract] [Full Text] [Related]

  • 12. Management of nonsevere pneumonia in military trainees with the urinary antigen test for Streptococcus pneumoniae: an innovative approach to targeted therapy.
    Guchev IA, Yu VL, Sinopalnikov A, Klochkov OI, Kozlov RS, Stratchounski LS.
    Clin Infect Dis; 2005 Jun 01; 40(11):1608-16. PubMed ID: 15889358
    [Abstract] [Full Text] [Related]

  • 13. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
    Sánchez ME, Gómez J, Gómez Vargas J, Baños V, Ruiz Gómez J, Muñoz L, Simarro E, Soto MC, Canteras M, Valdés M.
    Rev Esp Quimioter; 1998 Jun 01; 11(2):132-8. PubMed ID: 9795298
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults].
    Trémolières F, Mayaud C, Mouton Y, Weber P, Dellatolas F, Caulin E.
    Pathol Biol (Paris); 2005 Jun 01; 53(8-9):503-10. PubMed ID: 16181747
    [Abstract] [Full Text] [Related]

  • 15. Treatment of childhood complicated community-acquired pneumonia with amoxicillin/sulbactam.
    Lovera D, Arbo A.
    J Chemother; 2005 Jun 01; 17(3):283-8. PubMed ID: 16038522
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK, Nopmaneejumruslers C, Chan CK.
    Am J Med; 2004 Mar 15; 116(6):385-93. PubMed ID: 15006587
    [Abstract] [Full Text] [Related]

  • 17. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
    Dinur-Schejter Y, Cohen-Cymberknoh M, Tenenbaum A, Brooks R, Averbuch D, Kharasch S, Kerem E.
    Pediatr Pulmonol; 2013 Jan 15; 48(1):52-8. PubMed ID: 22431471
    [Abstract] [Full Text] [Related]

  • 18. Levofloxacin versus ceftriaxone plus clarithromycin in the treatment of adults with community-acquired pneumonia requiring hospitalization.
    Querol-Ribelles JM, Tenías JM, Querol-Borrás JM, Labrador T, Nieto A, González-Granda D, Martínez I.
    Int J Antimicrob Agents; 2005 Jan 15; 25(1):75-83. PubMed ID: 15620830
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy and safety of clarithromycin in the treatment of community-acquired pneumonia].
    Parola D, Dell'Orso D, Terzano C.
    Recenti Prog Med; 2000 Jan 15; 91(1):12-5. PubMed ID: 10705778
    [Abstract] [Full Text] [Related]

  • 20. [A pharmacoeconomic study of in-hospital treatment against community-acquired pneumonia].
    Bermejo Vicedo T, Torralba Arranz A, Hidalgo Correas FJ, Millán Santos I, Rodríguez Morradan B.
    Farm Hosp; 2004 Jan 15; 28(1):29-35. PubMed ID: 15012176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.